» Articles » PMID: 27793880

MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy

Overview
Journal Anticancer Res
Specialty Oncology
Date 2016 Oct 30
PMID 27793880
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) constitute a dominating class of small RNAs that regulate diverse cellular functions. Due the pivotal role of miRNAs in biological processes, a deregulated miRNA expression is likely involved in human cancers. MicroRNAs possess tumor suppressor capability, as well as display oncogenic characteristics. Interestingly, miRNAs exist in various biological fluids as circulating entities. Changes in the profile of circulating miRNAs are indicative of pathophysiological conditions in human cancer. This concept has led to consider circulating miRNAs valid biomarkers in cancer diagnostics. Furthermore, current research promotes the use of miRNAs as a target in cancer therapy. However, miRNAs are an evolving research field. Although miRNAs have been demonstrated to be potentially valuable tools both in cancer diagnosis and treatment, a greater effort should be made to improve our understanding of miRNAs biology. This review describes the biology of microRNAs, emphasizing on the use of miRNAs in cancer diagnostics and therapy.

Citing Articles

MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway.

Yan L, Zhou R, Feng Y, Li R, Zhang L, Pan Y Cell Death Discov. 2024; 10(1):193.

PMID: 38664375 PMC: 11045734. DOI: 10.1038/s41420-024-01946-z.


The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.

Zheng C, Li R, Zheng S, Fang H, Xu M, Zhong L Cancer Sci. 2023; 114(12):4747-4762.

PMID: 37817462 PMC: 10728003. DOI: 10.1111/cas.15989.


Oral squamous cell carcinomas: state of the field and emerging directions.

Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S Int J Oral Sci. 2023; 15(1):44.

PMID: 37736748 PMC: 10517027. DOI: 10.1038/s41368-023-00249-w.


miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation.

Hirabayashi K, Miyazawa M, Takanashi Y, Morimachi M, Kawanishi A, Saika T Sci Rep. 2022; 12(1):17927.

PMID: 36289359 PMC: 9606280. DOI: 10.1038/s41598-022-22950-2.


Optical bio-sensing of DNA methylation analysis: an overview of recent progress and future prospects.

Adampourezare M, Hasanzadeh M, Seidi F RSC Adv. 2022; 12(39):25786-25806.

PMID: 36199327 PMC: 9460980. DOI: 10.1039/d2ra03630d.